Literature DB >> 31204538

Quality assessment criteria: psychometric properties of measurement tools for cancer related fatigue.

Mohammed Al Maqbali1, Ciara Hughes1, Jackie Gracey1, Jane Rankin2, Lynn Dunwoody3, Eileen Hacker4.   

Abstract

Background: Fatigue is a common and distressing cancer symptom that negatively affects the quality of life. Many scales have been developed to assess cancer-related fatigue. The properties of the scales vary in terms of dimensionality, reliability, validity, length and method of administration. Insufficient of psychometric properties may affect the accuracy of scales findings, that may lead result obtained questionable. The main objective of this review was to conduct a quality assessment of the psychometric properties of cancer-related fatigue scales to identify appropriate scales that could be used in research and clinical practice. Method: A systematic search was carried out to identify validated scales that measure cancer-related fatigue. Five databases were searched: CINAHL, MEDLINE, EMBASE, PsycINFO, Cochrane Library. This review was conducted following the PRISMA and Terwee et al.'s quality assessment guidelines to evaluate the psychometric properties of the studies. Result: Seventy-one different studies published between 1970 and 2018 met the inclusion criteria. Twenty-five scales were identified. Of these, eighteen were multidimensional and seven were uni-dimensional, containing between 4 and 72 items. Reliability and/or validity information was missing for many scales. Four scales met the quality assessment criteria and were reported as the most appropriate for measuring fatigue in cancer patients.
Conclusion: Further psychometric testing is required for other scales. Developing a universally-defined tool kit for the assessment of cancer-related fatigue may help clarify the concept of fatigue and promote a systematic approach to fatigue measurement.

Entities:  

Year:  2019        PMID: 31204538     DOI: 10.1080/0284186X.2019.1622773

Source DB:  PubMed          Journal:  Acta Oncol        ISSN: 0284-186X            Impact factor:   4.089


  8 in total

1.  Doc, I feel tired… oh really, so how's your mucositis?

Authors:  Kord M Kober; Sue S Yom
Journal:  Cancer       Date:  2021-05-24       Impact factor: 6.921

Review 2.  Cancer-related fatigue in patients treated with mistletoe extracts: a systematic review and meta-analysis.

Authors:  Florian Pelzer; Martin Loef; David D Martin; Stephan Baumgartner
Journal:  Support Care Cancer       Date:  2022-03-03       Impact factor: 3.359

3.  Application of the Multidimensional Fatigue Inventory to Ethiopian Cancer Patients.

Authors:  Yemataw Wondie; Andreas Hinz
Journal:  Front Psychol       Date:  2021-12-02

4.  Comparative responsiveness and minimally important difference of Fatigue Symptom Inventory (FSI) scales and the FSI-3 in trials with cancer survivors.

Authors:  Catherine E Mosher; Ekin Secinti; Shelley A Johns; Kurt Kroenke; Laura Q Rogers
Journal:  J Patient Rep Outcomes       Date:  2022-07-23

5.  Psychometric Properties of the Spanish Version of the Fatigue Assessment Scale in Caregivers of Palliative Care Patients.

Authors:  Ana A Esteban-Burgos; Manuel Fernández-Alcántara; Silvia Escribano; Juana Perpiñá-Galvañ; Concepción Petra Campos-Calderón; María José Cabañero-Martínez
Journal:  J Clin Med       Date:  2022-07-11       Impact factor: 4.964

6.  Prediction of evening fatigue severity in outpatients receiving chemotherapy: less may be more.

Authors:  Kord M Kober; Ritu Roy; Anand Dhruva; Yvette P Conley; Raymond J Chan; Bruce Cooper; Adam Olshen; Christine Miaskowski
Journal:  Fatigue       Date:  2021-02-16

7.  Validation of the Multidimensional Fatigue Inventory with Coronary Artery Disease Patients.

Authors:  Julija Gecaite-Stonciene; Adomas Bunevicius; Julius Burkauskas; Julija Brozaitiene; Julius Neverauskas; Narseta Mickuviene; Nijole Kazukauskiene
Journal:  Int J Environ Res Public Health       Date:  2020-10-30       Impact factor: 3.390

8.  Longitudinal exploration of cancer-related cognitive impairment in patients with newly diagnosed aggressive lymphoma: protocol for a feasibility study.

Authors:  Priscilla Gates; Karla Gough; Haryana Dhillon; Carlene Wilson; Eliza Hawkes; Vincent Dore; Yuliya Perchyonok; Christopher C Rowe; Adam K Walker; Janette L Vardy; Michiel de Ruiter; Meinir Krishnasamy
Journal:  BMJ Open       Date:  2020-09-29       Impact factor: 2.692

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.